Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Malaise, Pancreatitis, Syncope
Clinical narrative: Severe pancreatitis; Atrial fibrillation; Collapsed at work; She was not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of PANCREATITIS (Severe pancreatitis), ATRIAL FIBRILLATION (Atrial fibrillation) and SYNCOPE (Collapsed at work) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 80777-273-10) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Aug-2021, the patient experienced MALAISE (She was not feeling well). On 28-Aug-2021, the patient experienced PANCREATITIS (Severe pancreatitis) (seriousness criteria hospitalization and medically significant), ATRIAL FIBRILLATION (Atrial fibrillation) (seriousness criteria hospitalization and medically significant) and SYNCOPE (Collapsed at work) (seriousness criteria hospitalization and medically significant). The patient was hospitalized from 28-Aug-2021 to 03-Sep-2021 due to ATRIAL FIBRILLATION, PANCREATITIS and SYNCOPE. The patient was treated with APIXABAN (ELIQUIS) ongoing since an unknown date for Adverse event, at a dose of 5 milligram twice a day and DILTIAZEM ongoing since an unknown date for Adverse event, at a dose of 240 milligram once a day. At the time of the report, PANCREATITIS (Severe pancreatitis) and ATRIAL FIBRILLATION (Atrial fibrillation) had not resolved and SYNCOPE (Collapsed at work) and MALAISE (She was not feeling well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was on the monitor for 2 weeks. She was released prematurely on 3SEPT2021 because hospital around the area had to make bed available for COVID 19. She was still undergoing the side effects of her diagnosis.  No concomitant medications were reported.  Company comment This case concerns a 69-year-old, female patient, with no disclosed medical history, who experienced the serious, unexpected events of syncope, pancreatitis and atrial fibrillation. The events occurred  4 days after first dose of Moderna vaccine. The patient did not feel well the day after the vaccine, and 4 days after collapsed at work, was admitted for pancreatitis and atrial fibrillation. The rechallenge is not applicable as patient received treatment for the events. The benefit-risk relationship of Moderna vaccine is not affected by this report.; Sender's Comments: This case concerns a 69-year-old, female patient, with no disclosed medical history, who experienced the serious, unexpected events of syncope, pancreatitis and atrial fibrillation. The events occurred  4 days after first dose of Moderna vaccine. The patient did not feel well the day after the vaccine, and 4 days after collapsed at work, was admitted for pancreatitis and atrial fibrillation. The rechallenge is not applicable as patient received treatment for the events. The benefit-risk relationship of Moderna vaccine is not affected by this report.